deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT04523142

CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004

A Phase 3, Multi-center, Open-label, Single-arm Clinical Trial to Assess the Long-term Safety and Tolerability of Topical CyclASol® for the Treatment of Dry Eye Disease in Subjects Who Completed the Clinical Trial CYS-004

Sponsor: Novaliq GmbH

Updated 10 times since 2020 Last updated: Sep 19, 2023 Started: Jan 4, 2021 Primary completion: Apr 30, 2022 Completion: May 23, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Dry Eye Disease (DED) and is currently completed. Novaliq GmbH leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshotRecruiting~Apr 2021 – ~Oct 2021 · 6 months · monthly snapshotRecruiting~Oct 2021 – ~Sep 2022 · 11 months · monthly snapshotActive Not Recruiting~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshotCompleted~Jan 2023 – ~Nov 2023 · 10 months · monthly snapshotCompleted~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Nov 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2023 — Nov 2023 [monthly]

    Completed PHASE3

  5. Sep 2022 — Jan 2023 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

Show 5 earlier versions
  1. Oct 2021 — Sep 2022 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  2. Apr 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  3. Feb 2021 — Apr 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  4. Jan 2021 — Feb 2021 [monthly]

    Not Yet Recruiting PHASE3

  5. Sep 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Novaliq GmbH
Data source: Novaliq GmbH

For direct contact, visit the study record on ClinicalTrials.gov .